Open AccessA Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease
Author(s) -
David M. Marks,
ChiUn Pae,
Ashwin A. Patkar
Publication year - 2014
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01658
Subject(s) - milnacipran , sciatica , lumbosacral joint , medicine , radicular pain , placebo , double blind , anesthesia , placebo controlled study , chronic pain , lumbar , surgery , physical therapy , antidepressant , alternative medicine , pathology , hippocampus
The current study investigates whether milnacipran, an equipotent serotonin-norepinephrine reuptake inhibitor, is effective in reducing chronic radicular pain in patients (N = 11) with lumbosacral disc disease.